NeoRx will be presenting Pretarget Lymphoma data at ASCO per Melinda Kile. With that and the current market conditions in mind, nerx (at these levels) may be the safest place to park money for the next month. I don't see an immediate turn around for the nazdaq in sight, at least while the big investment firms are being "investigated" (as they should be). If you are long this stock, just turn the computer off. I have good feeling we will be rewarded. Remember the science involved here.
Pretarget can kill human cancer in mice with one high dose without harming the mice. That is "established human cancer" in "mice". If you really think about you can see how the stock could run to $70. The single high dose erradicated the human cancer. The single high dose did not arm the mice. How much better would a 150 lb man tolerate this high dose as compared to an 8 ounce mouse? Remember, it was human cancer. - My advice, don't sell for $2.60. This is the beginning, not the end. Oh yeah, and to willy and rangerbaseball, GO TRIBE !!!!!
Yeah but it is mouse metabolism. Tell me about T1/2, volume of distribution, clearance rate, and the ADME side of the fence for a mouse vs humans??
Clean out your headgear newbie. If that Logic held NERX would have never been founded because cancer would have been cured 20 years ago. Go back to investing in REITs you clearly don't know bunk about pharma.
Oh the humanity, how can this be so easy?? Oh yeah, people like you...